VTRS
Viatris Inc.
Drug Manufacturers - Specialty & Generic · Healthcare · United States
16.04
close · 2026-08-13
value
94
cheaper than peers94
quality
45
stronger fundamentals45
ranked against
Drug Manufacturers - Specialty & Generic
value
quality
34 peerswide variation
Value inputs
| measure | company | vs peers |
| forward P/E | 6.03× | 91 |
| price to book | 1.27× | 88 |
| EV to EBITDA | 7.22× | 83 |
| price to sales | 1.27× | 82 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | 12.6% | 63 |
| debt to equity | 95.5% | 50 |
| return on equity | -2.8% | 43 |
| revenue growth | 4.9% | 39 |
4 of 4 measures available
Facts
| market cap | $18B |
| free cash flow | $2.68B |
| employees | 30,000 |
| first trade | 1980-03-17 |
| next earnings | 2026-08-06 |
| fundamentals updated | 2026-08-10 |